Contact Sensitization and Phototoxic and Photoallergic Potential of Tirbanibulin 1% Ointment in Healthy Volunteers

Tirbanibulin 1% ointment is approved for the topical treatment of actinic keratosis, applied once daily for 5 days. Three phase 1 randomized, single-center, controlled, within-subject comparison studies were conducted to evaluate the sensitization (KX01-AK-006), phototoxic (KX01-AK-008), and photoal...

Descripción completa

Detalles Bibliográficos
Autores principales: Dosik, Jonathan, Cutler, David L., Fang, Jane, Padullés, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868847/
https://www.ncbi.nlm.nih.gov/pubmed/36699198
http://dx.doi.org/10.1016/j.xjidi.2022.100170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868847/
https://www.ncbi.nlm.nih.gov/pubmed/36699198
http://dx.doi.org/10.1016/j.xjidi.2022.100170

Ejemplares similares